| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5945792 | Atherosclerosis | 2014 | 4 Pages |
Abstract
Raising HDL levels with the CETP inhibitor torcetrapib improves glucose homeostasis in dyslipidemic and insulin resistant hamsters. Whether similar effect would be observed with other CETP inhibitors should be investigated.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
François Briand, Bénédicte Prunet-Marcassus, Quentin Thieblemont, Clément Costard, Elodie Muzotte, Sylvie Sordello, Thierry Sulpice,